Chapters and Manuals
Articles
Vaccine Licensures and Recommendations
- Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women—Advisory Committee on Immunization Practices (ACIP), 2012. MMWR. 2013;62(07):131—5.
- Updated Recommendation for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine in Adults 65 Years and Older—Advisory Committee on Immunization Practices (ACIP), 2012. MMWR. 2012;61(25):468—70.
- Immunization of Health-Care Personnel: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2011;60(RR07):1—45.
- Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged Less than 12 Months—Advisory Committee on Immunization Practices (ACIP), 2011. MMWR. 2011;60(41):1424—6.
- FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine. MMWR. 2011;60(37):1279—80.
- General Recommendations on Immunization. MMWR. 2011;60(RR02):1—60.
- Updated Recommendations for the Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR. 2011;60(01):13—15.
- Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and their Infants. MMWR. 2008;5(04):1—47.
- Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine. MMWR. 2006;55(RR17):1—33.
- Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines. MMWR. 2006;55(RR3):1—34.
- Combination Vaccines for Childhood Immunization. MMWR. 1999;48(RR05):1—15.
- Diphtheria, Tetanus, and Pertussis: Recommendations for Vaccine Use. MMWR. 1991;40(RR10):1—28.
Surveillance, Epidemiology and Outbreaks
- CDC. Notes from the field: Respiratory diphtheria-like illness caused by toxigenic Corynebacterium ulcerans—Idaho, 2010 MMWR. 2011;60 (03):77.
- CDC. Fatal respiratory diphtheria in a U.S. traveler to Haiti—Pennsylvania, 2003 MMWR. 2004;52(53):1285—6.
- CDC. Toxigenic Corynebacterium diphtheriae—Northern Plains Indians MMWR. 1997;46(22):506—10.
- Availability of diphtheria antitoxin through an Investigational New Drug protocol MMWR. 2004;53(19):413.
- Bisgard KM, Hardy IRB, Popovic T, et al. Respiratory diphtheria in the United States, 1980 through 1995. Am J Public Health. 1998;88:787—91.
- Dittmann S. Epidemic diphtheria in the Newly Independent States of the former USSR—Situation and lessons learned. Int Assoc Biol Standard. 1997;25:179—86.
- Farizo KM, Strebel PM, Chen RT, et al. Fatal respiratory disease due to Corynebacterium diphtheriae: Case report and review of guidelines for management, investigation, and control. Clin Infect Dis. 1993;16: 59—68.
Laboratory
- Bolt F, Cassiday P, Tondella ML, et al. Multilocus sequence typing identifies evidence for recombination and two distinct lineages of Corynebacterium diphtheriae. J Clin Microbiol. 2010;48:4177—85.
- Hall AJ, Cassiday PK, Bernard KA, et al. Isolation of novel Corynebacterium diphtheriae from domestic cats. Emerg Infect Dis. 2010;16:688—91.
- Cassiday PK, Pawloski LC, Tiwari T, et al. Analysis of toxigenic Corynebacterium ulcerans strains revealing potential for false-negative real-time PCR results. J Clin Microbiol. 2009; 46:331—3.
- Mothershed EA, Cassiday PK, Pierson K, et al. Development of a real-time flourescent PCR assay for rapid detection of the diphtheria toxin gene. J Clin Microbiol. 2002;40:4713—19.
- Popovic T, Kim C, Reiss JA, et al. Use of molecular subtyping to document long-term persistence of Corynebacterium diphtheriae in South Dakota. J Clin Microbiol. 1999;37:1092—9.
Top of Page
- Page last reviewed: January 15, 2016
- Page last updated: January 15, 2016
- Content source:
Top